Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Expedia Group Inc (EXPE) vs Teladoc Health Inc (TDOC) Price & Performance

Expedia Group IncTrade
Teladoc Health IncTrade

Price performance (Past 24H)

Key statistics

Expedia Group Inc vs Teladoc Health Inc — how do they compare? Expedia Group Inc trades at $264.76 (market cap $32.06B), while Teladoc Health Inc trades at $9.59 (market cap $1.75B). The key difference: Expedia Group Inc is far larger — about 18.3× Teladoc Health Inc's market cap, and Expedia Group Inc pays a 0.66% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals.

EXPETDOC
Market Cap
$32.06B$1.75B
Sector
Consumer CyclicalHealth
52-Week High
$301.31$9.72
52-Week Low
$178.06$4.47
Enterprise Value
$30.97B$2.04B
Dividend Yield
0.66%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Expedia Group Inc

Expedia Group (EXPE) trades at $264.76, down 0.57% on the day, with a bullish technical outlook supported by moving averages. The company shows strong fundamentals with revenue growth to $14.73B in 2025 and consistent earnings beats, including Q1 2026 EPS of $1.96 versus $1.41 expected. Recent developments include a strategic partnership with Allegiant Travel and positive analyst coverage highlighting growth potential. Valuation metrics include a P/E of 23.6 and P/S of 2.29, indicating reasonable pricing relative to peers.

The outlook for EXPE is positive, driven by robust travel demand, strategic initiatives, and a consensus price target of $292.09 implying ~10% upside. Key risks include macroeconomic sensitivity affecting travel spending and competitive pressures. Institutional sentiment is bullish with 45% buy ratings, though investors should monitor execution on growth targets and industry cyclicality.

Teladoc Health Inc

TDOC trades at $9.56, up 3.13% with bullish technical signals from moving averages. The company reported mixed Q1 2026 earnings, missing expectations with a -$0.36 EPS, but maintains strong revenue of $2.53B and a gross margin of 69.29%. Recent partnership expansions with Walmart highlight growth initiatives, though net losses persist at -$200.32M. Analyst consensus is mixed with 35.71% buy ratings but a price target below current levels at $8.75.

The outlook remains cautious due to ongoing net losses and negative cash flow trends, with net cash flow at -$517.24M in 2025. Key risks include competitive pressures and execution challenges, but cost-cutting and market expansion could support recovery. Investors should weigh the low P/S ratio of 0.69 against profitability concerns.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Expedia Group Inc

Expedia is the world's largest online travel agency by bookings, offering services for lodging (75% of total 2021 sales), air tickets (3%), rental cars, cruises, in-destination, and other (15%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, including Expedia.com, Hotels.com, Travelocity, Orbitz, Wotif, AirAsia, and Vrbo. It has also expanded into travel media with the acquisition of Trivago. Transaction fees for online bookings account for the bulk of sales and profits.

Read more on EXPE

About Teladoc Health Inc

Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.

Read more on TDOC